These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17560110)

  • 21. Tricyclic HIV integrase inhibitors: VI. SAR studies of 'benzyl flipped' C3-substituted pyrroloquinolines.
    Metobo S; Mish M; Jin H; Jabri S; Lansdown R; Chen X; Tsiang M; Wright M; Kim CU
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1187-90. PubMed ID: 19167883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and structural analysis of HIV-1 integrase conservation.
    Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
    AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in the study of HIV-1 integrase inhibitor of aryl beta-diketoacids].
    Wang C; Zhao GS
    Yao Xue Xue Bao; 2006 Sep; 41(9):801-7. PubMed ID: 17111823
    [No Abstract]   [Full Text] [Related]  

  • 25. 3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as advanced inhibitors of HIV integrase.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2007 Aug; 15(16):5487-92. PubMed ID: 17560110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 integrase inhibitors: 2005-2006 update.
    Dayam R; Gundla R; Al-Mawsawi LQ; Neamati N
    Med Res Rev; 2008 Jan; 28(1):118-54. PubMed ID: 17979144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.
    Meadows DC; Tantillo DJ; Gervay-Hague J
    ChemMedChem; 2006 Sep; 1(9):959-64. PubMed ID: 16952140
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure Based Drug Design: Clinically Relevant HIV-1 Integrase Inhibitors.
    Kaur M; Rawal RK; Rath G; Goyal AK
    Curr Top Med Chem; 2018; 18(31):2664-2680. PubMed ID: 30659539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New approaches for inhibiting HIV integrase: a journey beyond the active site.
    Walker MA
    Curr Opin Investig Drugs; 2009 Feb; 10(2):129-36. PubMed ID: 19197790
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.